RIZE — Rize Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.27m
- CA$0.68m
Annual cashflow statement for Rize Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.64 | -1.72 | -0.688 | -0.551 | -1.25 |
| Non-Cash Items | 0.685 | 0.812 | 0.171 | 0.024 | 0.34 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.212 | -0.274 | 0.052 | 0.061 | -0.148 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -0.74 | -1.18 | -0.465 | -0.466 | -1.06 |
| Capital Expenditures | — | — | — | — | -0.15 |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | — | — | — | — | -0.15 |
| Financing Cash Flow Items | — | — | — | 0.347 | 0.357 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.875 | 3 | — | 0.347 | 0.357 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.134 | 1.62 | -0.432 | -0.202 | -0.816 |